4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075198
10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 10% owner acquired 3,433,646 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
VIVO VENTURES VII, LLC · 10% owner
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-10-13 | Conversion : show line 1 in the form | +3,360,408 | 3,657,147 | I | ||
| 2015-10-13 | Purchase : show line 2 in the form | +444,850 | $11.00 | $4,893,350 | 4,101,997 | I |
| 2015-10-13 | Conversion : show line 3 in the form | +73,238 | 79,705 | I | ||
| 2015-10-13 | Purchase : show line 4 in the form | +9,695 | $11.00 | $106,645 | 89,400 | I |
| Open-market purchases · 454,545 sh · avg $11.00 · $4,999,995 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-10-13 | Conversion : show line 5 in the form Series A Preferred Stock | −8,467,943 | 0 | I |
| 2015-10-13 | Conversion : show line 6 in the form Series A Preferred Stock | −184,557 | 0 | I |
| 2015-10-13 | Conversion : show line 7 in the form Series B Preferred Stock | −1,779,400 | 0 | I |
| 2015-10-13 | Conversion : show line 8 in the form Series B Preferred Stock | −38,782 | 0 | I |
| 2015-10-13 | Conversion : show line 9 in the form Series C Preferred Stock | −1,346,068 | 0 | I |
| 2015-10-13 | Conversion : show line 10 in the form Series C Preferred Stock | −29,337 | 0 | I |
Loading xslF345X03/doc4.xml…